Related Experiment Videos

[Serum cholinesterase activity (CHE) in different classes of chronic liver diseases (author's transl)]

Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio
|March 1, 1978
PubMed

Insights

Cholinesterase (ChE) levels are lower in patients with chronic hepatitis and cirrhosis. Monitoring ChE may help predict outcomes for cirrhosis patients, with alcoholic cases showing the most significant decrease.

Area of Science:

  • Biochemistry
  • Hepatology
  • Clinical Chemistry

Context:

  • Investigates cholinesterase (ChE) activity in patients with chronic liver diseases.
  • Compares ChE levels across different classes of chronic hepatitis and cirrhosis.
  • Includes a cohort of 193 patients with diverse liver conditions.

Purpose:

  • To determine the diagnostic and prognostic value of serum cholinesterase activity in chronic liver disease.
  • To compare ChE levels in various forms of chronic hepatitis and cirrhosis.
  • To assess the correlation between ChE levels and etiological factors like alcohol consumption.

Summary:

  • Serum cholinesterase (ChE) activity was significantly lower in patients with chronic active hepatitis (CAH) and cirrhosis compared to healthy controls.
  • No significant difference in ChE levels was observed between HBsAg-positive and HBsAg-negative CAH cases.
  • Alcoholic cirrhotics exhibited markedly lower serum ChE levels than non-alcoholic patients.
  • Follow-up monitoring of serum ChE levels shows potential utility in predicting the prognosis of cirrhotic patients.

Impact:

  • Highlights serum cholinesterase as a potential biomarker for liver disease severity and progression.
  • Provides insights into the differential impact of etiological factors on liver synthetic function.
  • Suggests a role for ChE monitoring in clinical management and prognostic assessment of cirrhosis.

Related Concept Videos